Trump DOJ Moves to Pause Missouri Lawsuit Targeting Abortion Pill Mail Access
The Trump administration is asking a federal judge to pause another lawsuit challenging nationwide access to the abortion pill mifepristone. The request could delay a major legal fight over how the medication is regulated.
The lawsuit was filed by a coalition of states led by Missouri seeking to roll back Biden-era rules that expanded how the drug can be distributed. Those changes allow patients to obtain the medication through telemedicine and receive it by mail.
According to OSV News, the U.S. Department of Justice filed a motion March 6 asking the court to pause the case known as Missouri v. FDA. Federal attorneys said the court should either stay the case or dismiss it while the Food and Drug Administration reviews its policies governing the drug.
Download a FREE Pocket Constitution NOW
But the timeline for that review remains unclear, raising questions about whether the lawsuit could remain stalled for months or longer. The administration has already made a similar request in a separate Louisiana-led case targeting the same abortion pill rules.
DOJ lawyers wrote the court should “stay this case until after FDA completes its review or dismiss it.”
The outcome matters because medication abortions now account for a majority of abortions in the United States, making the regulation of mifepristone one of the most significant fronts in the post-Roe legal landscape.
If the judge agrees to pause the case, the dispute could effectively shift to the FDA’s regulatory process rather than the courts. If the motion is denied, the lawsuit could move forward and potentially reshape how the drug is distributed nationwide.
The court has not yet ruled on the administration’s request.
Follow The Coffman Chronicle on NewsBreak for daily breaking political coverage.